| (210) | Number of the EPO application | 17807900 |
| (220) | Filing date of the EPO application | 2017.11.22 |
| (80) | EPO patent specification publication (B) | EPB nr. 25/2021, 2021.06.23 |
| (110) | EPO patent number | 3544981 |
| (21) | Number of the application | e 2019 1102 |
| (71) | Name(s) of applicant(s), code of the country | Enterprise Therapeutics Limited, GB; |
| (72) | Name(s) of inventor(s), code of the country | MCCARTHY Clive, GB;
HARGRAVE Jonathan David, GB;
HAY Duncan Alexander, GB;
SCHOFIELD Thomas Beauregard, GB;
WENT Naomi, GB; |
| (73) | Name(s) of owner(s), code of the country | Enterprise Therapeutics Limited, GB; |
| (54) | Title of the invention | BENZODIAZOLIUM COMPOUNDS AS ENAC INHIBITORS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 487/04 (2006.01.01); A61P 11/12 (2006.01.01); A61K 31/4985 (2006.01.01) |
| (19) | Country | GB |
| (41) | Date of publication of the application | 2019.11.30 |
| (30) | Priority | 201619694, 2016.11.22, GB |
| (86) | International application | PCT/GB2017/053499, 2017.11.22 |
| (87) | International publication | WO 2018/096325, 2018.05.31 |